SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,917.85 1,225.07
( 1.62%)

Global Indices

Nasdaq

52,165.19 373.88
(0.72%)

Dow Jones

7,596.72 -4.35
(-0.06%)

Hang Seng

63,112.86 -177.25
(-0.28%)

Nikkei 225

10,768.78 39.00
(0.36%)

Forex

USD-INR

94.93 -0.28
(-0.30%)

EUR-INR

105.90 -0.29
(-0.27%)

GBP-INR

127.09 0.08
(0.06%)

JPY-INR

0.60 0.00
(-0.15%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Morepen Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500288

INE083A01026

24.8934982

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

MOREPENLAB

33.77

5920.64

EPS(TTM)

Face Value()

Div & Yield %

3.2

0.19

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	1681.20	1554.54	1537.59	1338.88	1449.27	1112.42
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	1681.20	1554.54	1537.59	1338.88	1449.27	1112.42
Other Income	22.59	15.72	12.57	5.76	10.24	11.77
Stock Adjustments	-3.23	44.36	-5.13	-16.54	-1.74	41.98
Total Income	1700.56	1614.62	1545.03	1328.10	1457.77	1166.17
EXPENDITURE :
Raw Materials	1058.13	1019.99	945.15	886.48	988.81	778.60
Power & Fuel Cost	44.90	40.62	34.09	23.78	18.93	13.00
Employee Cost	206.28	177.22	160.28	146.19	150.00	123.20
Other Manufacturing Expenses	76.80	68.03	44.19	33.81	23.39	13.57
Selling & Administrative Expenses	148.10	118.39	163.47	111.62	87.90	82.36
Miscellaneous Expenses	31.68	21.23	23.47	43.19	49.36	31.30
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	1565.89	1445.48	1370.64	1245.08	1318.39	1042.03
Operating Profit	134.67	169.13	174.39	83.03	139.37	124.15
Interest	16.10	7.10	3.51	1.98	-7.37	1.79
Gross Profit	118.57	162.03	170.88	81.05	146.74	122.36
Depreciation	29.31	24.44	21.90	18.01	21.19	28.11
Profit Before Tax	89.26	137.59	148.98	63.04	125.55	94.25
Tax	14.71	31.28	38.48	16.60	22.00	0.00
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	8.49	4.73	-0.44	0.20	2.48	0.00
Reported Net Profit	66.06	101.58	110.94	46.24	101.06	94.25
Extraordinary Items	1.38	0.00	0.00	0.00	0.00	0.00
Adjusted Net Profit	64.68	101.58	110.94	46.24	101.06	94.25
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance brought forward	429.78	328.20	217.27	171.03	74.96	-19.29
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	10.86	0.00	0.00	0.00	5.00	0.00
P & L Balance carried down	484.98	429.78	328.20	217.27	171.03	74.96
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	10.00	10.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.20	0.20	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	1.21	1.85	2.17	0.90	2.12	2.10
Earnings Per Share(Adj)-Unit Curr	1.21	1.85	2.17	0.90	2.12	2.10
Book Value-Unit Curr	22.68	21.56	17.39	15.26	11.97	8.92
Book Value(Adj)-Unit Curr	22.68	21.56	17.39	15.26	11.97	8.92

76,917.85 1,225.07 ( 1.62%)

52,165.19 373.88 (0.72%)

7,596.72 -4.35 (-0.06%)

63,112.86 -177.25 (-0.28%)

10,768.78 39.00 (0.36%)

94.93 -0.28 (-0.30%)

105.90 -0.29 (-0.27%)

127.09 0.08 (0.06%)

0.60 0.00 (-0.15%)